BATS:TOKE

Cambria Cannabis ETF Stock Forecast, Price & News

$14.46
-0.12 (-0.82 %)
(As of 09/17/2021 04:00 PM ET)
Add
Today's Range
$14.39
$14.68
50-Day Range
$14.41
$17.52
52-Week Range N/A
Volume5,821 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TOKE News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambria Cannabis ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Cambria
Fund NameCambria Cannabis ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:TOKE
Inception Date7/25/2019
Fund ManagerMebane T. Faber
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
Benchmark
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$30.38 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.59%
Other Expenses0.00%
Total Expenses0.59%
Fee Waiver-0.17%
Net Expenses0.42%

Administrator, Advisor and Custodian

AdministratorSEI Investments Global Funds Services
AdvisorCambria Investment Management, L.P.
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market Maker

Geographic Exposure of TOKE

Currency Exposure of TOKE

Sector Exposure of TOKE

Industry Exposure of TOKE

speech bubbles
speech bubbles











Cambria Cannabis ETF (BATS:TOKE) Frequently Asked Questions

What stocks does MarketBeat like better than Cambria Cannabis ETF?

Wall Street analysts have given Cambria Cannabis ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cambria Cannabis ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Cambria Cannabis ETF's stock been impacted by Coronavirus?

Cambria Cannabis ETF's stock was trading at $10.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TOKE shares have increased by 41.6% and is now trading at $14.46.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of Cambria Cannabis ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambria Cannabis ETF investors own include AT&T (T), BP (BP), Corning (GLW), GrowGeneration (GRWG), Lumen Technologies (LUMN), AdvisorShares Pure US Cannabis ETF (MSOS), Rocky Mountain High Brands (RMHB), Agritek (AGTK), AbbVie (ABBV) and Bank of America (BAC).

What is Cambria Cannabis ETF's stock symbol?

Cambria Cannabis ETF trades on the BATS under the ticker symbol "TOKE."

How do I buy shares of Cambria Cannabis ETF?

Shares of TOKE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cambria Cannabis ETF's stock price today?

One share of TOKE stock can currently be purchased for approximately $14.46.


This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.